HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Non-Alcoholic Fatty Liver Disease & Liver Health

The increasing prevalence of obesity has contributed to the rise of non-alcoholic fatty liver disease & liver health concerns worldwide. NAFLD occurs when excess fat accumulates in the liver, leading to inflammation and potential progression to non-alcoholic steatohepatitis (NASH), cirrhosis, or liver failure. Insulin resistance, metabolic syndrome, and dyslipidemia are key factors driving fat deposition in hepatocytes. Beyond liver damage, NAFLD is strongly associated with an elevated risk of cardiovascular disease. Lifestyle interventions, including dietary modifications, exercise, and weight loss, remain the primary treatment strategies. Emerging pharmacological therapies targeting liver fat metabolism and inflammation are being developed to provide more effective interventions for managing obesity-related liver disease.

Committee Members
Speaker at World Obesity and Weight Management Congress 2025 - Russell Rising

Russell Rising

D & S Consulting Services Inc, United States
Speaker at World Obesity and Weight Management Congress 2025 - Jeane Silva

Jeane Silva

Augusta University, United States
Speaker at World Obesity and Weight Management Congress 2025 - F Buck Willis

F Buck Willis

Belize Bible College, Punta Gorda, Belize
WOC 2025 Speakers
Speaker at World Obesity and Weight Management Congress 2025 - Charles Bernard

Charles Bernard

Criteria for Success, Inc., United States
Speaker at World Obesity and Weight Management Congress 2025 - Nicolaus Dahlmann

Nicolaus Dahlmann

Institute for Biometry and Nutrition, Germany
Speaker at World Obesity and Weight Management Congress 2025 - Fabiana Sant Anna Evangelista

Fabiana Sant Anna Evangelista

University of Sao Paulo, Brazil
Speaker at World Obesity and Weight Management Congress 2025 - Colleen Lindsey

Colleen Lindsey

Leading Notes, United States
Tags

Submit your abstract Today

Watsapp